Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial

NCT00315120 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 455

Last updated 2016-07-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether osteopathic manipulative treatment (a type of spinal manipulative therapy used by osteopathic physicians) and ultrasound physical therapy are effective in the treatment of chronic low back pain.

Conditions

  • Low Back Pain

Interventions

PROCEDURE

A. Active OMT and active UST

Active osteopathic manipulation (OMT) and active ultrasound physical therapy (UST)

PROCEDURE

B. Sham OMT and active UST

Sham osteopathic manipulation (OMT) and active ultrasound physical therapy (UST)

PROCEDURE

C. Active OMT and sham UST

Active osteopathic manipulation (OMT) and sham ultrasound physical therapy (UST)

PROCEDURE

D. Sham OMT and sham UST

Sham osteopathic manipulation (OMT) and sham ultrasound physical therapy (UST)

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Osteopathic Heritage Foundations

    collaborator OTHER
  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • University of North Texas Health Science Center

    lead OTHER

Principal Investigators

  • John C. Licciardone, DO, MS, MBA · The Osteopathic Research Center, University of North Texas Health Science Center at Fort Worth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
21 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00315120 on ClinicalTrials.gov